Filtered By:
Vaccination: Pneomococcal Vaccine
This page shows you your search results in order of relevance. This is page number 19.
Order by Relevance | Date
Total 3041 results found since Jan 2013.
Systematic Review of Safety of RTS,S with AS01 and AS02 Adjuvant Systems Using Data from Randomized Controlled Trials in Infants, Children, and Adults
CONCLUSION: Most of the adverse events observed from RTS,S/AS01 and RTS,S/AS02 malaria vaccines were reported in the control group and shared by other vaccines. Hence, the authors concluded that both RTS,S/AS01 and RTS,S/AS02 malaria vaccines are safe.PMID:36941908 | PMC:PMC10024506 | DOI:10.2147/CPAA.S400155
Source: Clinical Pharmacology: Advances and Applications - March 21, 2023 Category: Allergy & Immunology Authors: Wubetu Yihunie Bekalu Kebede Bantayehu Addis Tegegne Melese Getachew Dehnnet Abebe Yibeltal Aschale Habtamu Belew Bereket Bahiru Source Type: research
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review
AbstractThis systematic review aims to summarize the impact of vaccination against influenza, shingles, and pneumococcus on the incidence on the risk of cardiovascular events in the elderly. This protocol was developed in accordance with PRISMA guidelines. We conducted a literature search and identified all relevant articles published regarding the matter up to September 2022. We retrieved 38 studies (influenza vaccine = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal vaccines significantly lower the risk of cardiovascular disease ...
Source: AGE - June 3, 2023 Category: Geriatrics Source Type: research
Barriers to and facilitators of populational adherence to prevention and control measures of COVID-19 and other respiratory infectious diseases: a qualitative evidence synthesis
Conclusions:
This review suggests that financial and social support, assertive communication, trust in political authorities and greater regulation of social media enhance adherence to prevention and control measures for COVID-19 and infectious respiratory diseases. Designing and implementing effective educational public health interventions targeting the findings of barriers and facilitators highlighted in this review are key to reducing the impact of infectious respiratory diseases at the population level.
Source: European Respiratory Review - June 21, 2023 Category: Respiratory Medicine Authors: Zaildo, T., Santino, T. A., Chaves, G., da Silva, B. A. K., Alchieri, J. C., Patino, C. M., Leite, S., Luz, K. G., Guerra, R. O., da Penha, T. H. S., da Silva, G. R., Jacome, A. C., Monteiro, K. S., de Mendonca, K. M. P. P. Tags: Respiratory infections and tuberculosis Reviews Source Type: research
Impact of influenza, herpes zoster, and pneumococcal vaccinations on the incidence of cardiovascular events in subjects aged over 65 years: a systematic review
AbstractThis systematic review aims to summarize the impact of vaccination against influenza, shingles, and pneumococcus on the incidence on the risk of cardiovascular events in the elderly. This protocol was developed in accordance with PRISMA guidelines. We conducted a literature search and identified all relevant articles published regarding the matter up to September 2022. We retrieved 38 studies (influenza vaccine = 33, pneumococcal vaccine = 5, and zoster vaccine = 2). A total of 28 and 2 studies have shown that influenza and pneumococcal vaccines significantly lower the risk of cardiovascular disease ...
Source: AGE - June 3, 2023 Category: Geriatrics Source Type: research
Flu Shot May Help Protect Diabetics From CV Hospitalization
This study shows that it may significantly reduce cardiovascular illness and death during flu season, and thus it is very important for this high-risk population to get vaccinated, she stressed. Dr Jacob A Udell (Peter Munk Cardiac Centre and Cardiovascular Division, University Health Network, and University of Toronto, ON), who was not involved with this study, agrees. These observational data provide " positive reinforcement of why we should be getting patients vaccinated, particularly patients who aren ' t over 65 but have diabetes, " he told heart wire . Before flu season starts, cardiologists, internists, and endoc...
Source: Dr Portnay - July 26, 2016 Category: Cardiology Authors: Dr Portnay Source Type: blogs
Perspectives on glucocorticoid treatment for COVID-19: a systematic review
This article aimed to review the studies that described the treatment with GC in COVID-19 patients. Randomized or nonrandomized clinical trials and retrospective or prospective-controlled longitudinal studies were screened for this systematic review. Studies in English, Portuguese, and Spanish published since 2019, with participants of any clinical status, geographic location, age, and sex were included. The most significant interest was related to the length of stay, radiological profile changes, viremia, and mortality. The research was done electronically on the Pubmed database using the following terms: "corticosteroids...
Source: Pharmacological Reports - March 5, 2021 Category: Drugs & Pharmacology Authors: Leonardo P Cordeiro Eduarda O N N Linhares Fernanda G O Nogueira Daniel Moreira-Silva Daniel J M Medeiros-Lima Source Type: research
The impact of the implementation of a clinical decision support system on the quality of healthcare services in a primary care setting
DISCUSSION: The electronic health record with CDS led to significantly improved uptake of immunizations and screening tests, with earlier diagnoses of breast and colon cancer. Evidence of improvement in chronic disease outcomes is still lacking.PMID:33681044 | PMC:PMC7928113 | DOI:10.4103/jfmpc.jfmpc_1728_20
Source: Primary Care - March 8, 2021 Category: Primary Care Authors: Ahmed Sherif Mahmoud Abdullah Alkhenizan Mohammed Shafiq Suad Alsoghayer Source Type: research
Adverse events following yellow fever vaccination in immunocompromised persons
Rev Inst Med Trop Sao Paulo. 2021 Mar 1;63:e13. doi: 10.1590/S1678-9946202163013. eCollection 2021.ABSTRACTThis observational retrospective study conducted during an yellow fever (YF) outbreak in Sao Paulo, Brazil, in 2017-2018, describes adverse events (AE) following YF vaccination of immunocompromised persons. Risks and benefits of vaccination were individually evaluated by physicians. AE were assessed by phone call or electronic mail, 14 to 90 days after vaccination. Three hundred and eighty one immunocompromised persons received a full-dose of YF vaccine. Their age ranged from 1.4 to 89.3 years (median 50.8 years); 53%...
Source: Revista do Instituto de Medicina Tropical de Sao Paulo - March 3, 2021 Category: Tropical Medicine Authors: Amanda Nazareth Lara Karina Takesaki Miyaji Karim Yaqub Ibrahim Marta Heloisa Lopes Ana Marli Christovam Sartori Source Type: research
